• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血在心力衰竭中的作用:文献综述。

The Role of Coagulation in Heart Failure: A Literature Review.

机构信息

Institute of Zoology, University of Punjab, Quaid-I-Azam Campus, Lahore, Pakistan.

Department of the Zoology, Lahore College for Women University, Lahore, Pakistan.

出版信息

Curr Heart Fail Rep. 2024 Aug;21(4):277-291. doi: 10.1007/s11897-024-00671-z. Epub 2024 Jun 13.

DOI:10.1007/s11897-024-00671-z
PMID:38869806
Abstract

PURPOSE OF REVIEW

This article summarizes the role of coagulation factors in the pathophysiology of heart failure including D-dimer, fibrinogen and fibrin, prothrombin, p-selectin, tissue factor, tissue plasminogen activator, von Willebrand factor, β-thromboglobulin, Factor XI, tissue thromboplastin, plasminogen activator inhibitor-1 (PAI-1), thrombomodulin, soluble urokinase-type plasminogen activator receptor (suPAR) and stuart-prower factor.

RECENT FINDINGS

The D-dimer, P-selectin, prothrombin, von Willebrand factor, tissue plasminogen activator, fibrinogen, suPAR, tissue factor, thrombomodulin and Factor XI play significant roles the pathophysiology of heart failure. However, no associations were found between β-thromboglobulin, tissue thromboplastin, PAI-1 and stuart-prower factor in the context of heart failure. Coagulation factors play significant role in the pathophysiology of heart failure. Consequently, the underlying pathophysiological mechanisms that explain changes in the cascade are closely related to the diagnostic, prognostic and therapeutic roles of coagulation cascade factors, which help physicians identify and treat heart failure.

摘要

目的综述

本文总结了凝血因子在心力衰竭的病理生理学中的作用,包括 D-二聚体、纤维蛋白原和纤维蛋白、凝血酶原、p-选择素、组织因子、组织型纤溶酶原激活物、血管性血友病因子、β-血栓球蛋白、因子 XI、组织型纤溶酶原激活物抑制剂-1(PAI-1)、血栓调节蛋白、可溶性尿激酶型纤溶酶原激活物受体(suPAR)和 Stuart-Prower 因子。

最近的发现

D-二聚体、p-选择素、凝血酶原、血管性血友病因子、组织型纤溶酶原激活物、纤维蛋白原、suPAR、组织因子、血栓调节蛋白和因子 XI 在心力衰竭的病理生理学中起着重要作用。然而,β-血栓球蛋白、组织因子、PAI-1 和 Stuart-Prower 因子与心力衰竭之间没有关联。凝血因子在心力衰竭的病理生理学中起着重要作用。因此,解释级联变化的潜在病理生理机制与凝血级联因子的诊断、预后和治疗作用密切相关,这有助于医生识别和治疗心力衰竭。

相似文献

1
The Role of Coagulation in Heart Failure: A Literature Review.凝血在心力衰竭中的作用:文献综述。
Curr Heart Fail Rep. 2024 Aug;21(4):277-291. doi: 10.1007/s11897-024-00671-z. Epub 2024 Jun 13.
2
Irregularities of Coagulation in Hypertension.高血压患者的凝血异常。
Curr Hypertens Rep. 2023 Oct;25(10):271-286. doi: 10.1007/s11906-023-01258-0. Epub 2023 Aug 10.
3
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.晚期慢性心力衰竭中的止血和炎症生物标志物:口服抗凝剂和心脏移植成功的作用
Br J Haematol. 2004 Jul;126(1):85-92. doi: 10.1111/j.1365-2141.2004.04977.x.
4
The Association between Coagulation and Atrial Fibrillation.凝血与心房颤动之间的关联。
Biomedicines. 2024 Jan 25;12(2):274. doi: 10.3390/biomedicines12020274.
5
Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.儿童溶血尿毒综合征中凝血和纤溶的激活。
Kidney Int. 1998 Oct;54(4):1324-30. doi: 10.1046/j.1523-1755.1998.00103.x.
6
Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.口服避孕药引起的血液凝固和纤维蛋白溶解变化以及雌激素对内皮细胞作用的研究。
Ann Hematol. 1993 Jul;67(1):33-6. doi: 10.1007/BF01709663.
7
Dyslipidemias and fibrinolysis.血脂异常与纤维蛋白溶解
Ital Heart J. 2002 Oct;3(10):579-86.
8
Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer.组织因子依赖性凝血激活及胃癌原位纤维蛋白溶解受损
Semin Thromb Hemost. 2003 Jun;29(3):291-300. doi: 10.1055/s-2003-40967.
9
The coagulation system changes in patients with chronic heart failure.慢性心力衰竭患者的凝血系统变化。
Medicina (Kaunas). 2010;46(9):642-7.
10
Associations between blood coagulation markers, NT-proBNP and risk of incident heart failure in older men: The British Regional Heart Study.老年男性血液凝固标志物、NT-前脑钠肽与新发心力衰竭风险之间的关联:英国地区心脏研究
Int J Cardiol. 2017 Mar 1;230:567-571. doi: 10.1016/j.ijcard.2016.12.056. Epub 2016 Dec 20.

引用本文的文献

1
Factor XI levels and the risk of cardiovascular events: a systematic review and meta-analysis of case-control and cohort studies.凝血因子XI水平与心血管事件风险:病例对照研究和队列研究的系统评价与荟萃分析
Res Pract Thromb Haemost. 2025 Jul 7;9(5):102968. doi: 10.1016/j.rpth.2025.102968. eCollection 2025 Jul.
2
Combination of sST2/LVMI Ratio and Modified MELD Scores Predicts Mortality in End-Stage Heart Failure.可溶性ST2/左心室质量指数比值与改良终末期肝病模型评分相结合可预测终末期心力衰竭患者的死亡率。
Int J Mol Sci. 2024 Dec 28;26(1):171. doi: 10.3390/ijms26010171.

本文引用的文献

1
The endogenous thrombin potential in patients with left ventricular assist device or heart transplant.植入左心室辅助装置或接受心脏移植患者的内源性凝血酶潜力
Front Med (Lausanne). 2023 Apr 12;10:1155496. doi: 10.3389/fmed.2023.1155496. eCollection 2023.
2
Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure.凝血因子 XI 通过肝-心对话保护心脏免于心力衰竭。
Science. 2022 Sep 23;377(6613):1399-1406. doi: 10.1126/science.abn0910. Epub 2022 Sep 22.
3
Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure.
可溶性尿激酶型纤溶酶原激活物受体水平与心力衰竭患者的结局。
J Card Fail. 2023 Feb;29(2):158-167. doi: 10.1016/j.cardfail.2022.08.010. Epub 2022 Sep 17.
4
Von Willebrand factor (vWF) in patients with heart failure with preserved ejection fraction (HFpEF): A retrospective observational study.患有射血分数保留型心力衰竭(HFpEF)的患者中的血管性血友病因子(vWF):一项回顾性观察性研究。
Medicine (Baltimore). 2022 Aug 5;101(31):e29854. doi: 10.1097/MD.0000000000029854.
5
The association of coagulation and atrial fibrillation: a systematic review and meta-analysis.凝血与心房颤动的关联:系统评价和荟萃分析。
Europace. 2023 Feb 8;25(1):28-39. doi: 10.1093/europace/euac130.
6
D-dimer and outcomes in hospitalized heart failure patients across the ejection fraction phenotypes.D-二聚体与射血分数表型住院心力衰竭患者结局的关系。
ESC Heart Fail. 2022 Oct;9(5):3060-3070. doi: 10.1002/ehf2.14049. Epub 2022 Jun 23.
7
D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.非瓣膜性心房颤动伴急性心力衰竭患者接受依度沙班治疗后的 D-二聚体水平。
J Cardiol. 2022 Jun;79(6):759-767. doi: 10.1016/j.jjcc.2022.01.005. Epub 2022 Feb 9.
8
Roles of the tissue-type plasminogen activator in immune response.组织型纤溶酶原激活物在免疫应答中的作用。
Cell Immunol. 2022 Jan;371:104451. doi: 10.1016/j.cellimm.2021.104451. Epub 2021 Nov 6.
9
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
10
Combined Assessment of D-Dimer with the Get with the Guidelines-Heart Failure Risk Score and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Acute Decompensated Heart Failure with Preserved and Reduced Ejection Fraction.射血分数保留和降低的急性失代偿性心力衰竭患者中D-二聚体与“遵循指南-心力衰竭风险评分”及N末端B型利钠肽原的联合评估
J Clin Med. 2021 Aug 13;10(16):3564. doi: 10.3390/jcm10163564.